DAWN

DAWN Deferred Revenue

$2.00MQuarterly · USD

Period ending:

DAWN FY Deferred RevenueUSD
DAWN FY Deferred Revenue2019-12-31: $0.002020-12-31: $0.002021-12-31: $0.002022-12-31: $0.002023-12-31: $0.002024-12-31: $1.55M2025-12-31: $2.00M$2.00M$0.00
2019-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

DAWN deferred revenue history

Revenue received but not yet earned. The available annual fiscal periods series contains 7 observations from Dec 31, 2019 to Dec 31, 2025.

Day One Biopharmaceuticals Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
2,000,000
1,554,000
0
0
0
0
0

Compare deferred revenue

All DAWN financial metrics · DAWN stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.